Bruker Corporation (BRKR) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

20/25

Growth 4 Margin 4 Expansion 5 Platform 2 Financial 5

latest quarter score

Earnings Reports

20
Bruker (BRKR) Q2 2026: Deep Tech Orders Surge 50%, Shifting Revenue Visibility Into 2027
August 04, 2026
13
Bruker (BRKR) Q4 2025: Cost Actions Target $140M+ as Margin Expansion Drives 2026 Recovery
June 15, 2026
14
Bruker (BRKR) Q4 2025: Cost Actions Drive 250–300 bps Margin Expansion Target Amid 1–2% Organic Growth Guide
June 15, 2026
23
Bruker (BRKR) Q1 2026: BSI Bookings Up High Single Digits, Cost Actions Drive Margin Visibility
May 06, 2026
21
Bruker (BRKR) Q3 2025: SEMI Segment Nears $300M, Signals High-Margin Expansion
November 03, 2025
11
Bruker (BRKR) Q2 2025: $120M Cost Cuts Target 300bps Margin Rebound Amid 7% Organic Decline
August 04, 2025
19
Bruker (BRKR) Q1 2025: $100M Policy and Tariff Headwind Forces Margin Defense, Sets Up 2026 Reset
July 06, 2025
Bruker (BRKR) Q3 2024: China Orders Down 20%, Delaying Recovery Despite 16% Revenue Growth
November 05, 2024
Bruker (BRKR) Q1 2024: Acquisitions Drive 400bps Guidance Lift, Margin Compression Signals Near-Term Integration Focus
May 02, 2024
Bruker (BRKR) Q4 2023: Organic Revenue Jumps 15.9% as Portfolio Expansion Accelerates Post-Genomic Tailwind
February 13, 2024

Browse all companies